Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000312069-25-000592·BARCLAYS PLC
Schedule 13G ownership disclosure
Zentalis Pharmaceuticals, Inc.
COMMON-STOCK · CUSIP: 98943L107
Event date: 2025-09-30
- Filing-level shares
- 3,841,449
- Percent of class
- 5.32%
- Barclays PLC
Shares: 3,841,449 · Class: 5.32%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000312069-25-000592
- Form type
- SCHEDULE 13G
- Filer
- BARCLAYS PLC
- CIK
- CIK 312069
- Filed
- Nov 12, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership